SLAMF7, also known as CD319, a SLAM (signaling lymphocytic activation molecule) family receptor, is relatively weakly expressed on chronic lymphocytic leukemia (CLL) B cells. Here, SLAMF7 is linked to B-cell chronic lymphocytic leukemia.